Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01601665 · ClinicalTrials.gov registry record
Post Approval Study of the AcrySof® IQ Toric Intraocular Lens (IOL) Models SN6AT6-SN6AT9
A clinical trial, sponsored by Alcon Research.
- Completed
- Registry status
- 477
- Enrollment target
NCT01601665 is a clinical trial that has completed, run by Alcon Research. The registered enrollment target is 477 participants.
The verdict
NCT01601665 has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- 477 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of toric high cylinder power intraocular lenses in a larger population in clinical practice and assure the continued safety of these approved devices.
Interventions
- DEVICE SN6AT6 Intraocular Lens
- DEVICE SN6AT7 Intraocular Lens
- DEVICE SN6AT8 Intraocular Lens
- DEVICE SN6AT9 Intraocular Lens
- DEVICE SN60WF Intraocular Lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 477 participants |
| Start Date | 2012-02 |
| Est. Completion | 2015-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01601665
The ClinicalTrials.gov registry entry for NCT01601665 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 477 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which SN6AT6 Intraocular Lens is the first listed.
NCT01601665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01601665 about?
NCT01601665 is a clinical study titled "Post Approval Study of the AcrySof® IQ Toric Intraocular Lens (IOL) Models SN6AT6-SN6AT9". The purpose of this study is to evaluate the use of toric high cylinder power intraocular lenses in a larger population in clinical practice and assure the continued safety of these approved devices.
What is the current status of trial NCT01601665?
This trial is currently completed. The enrollment target is 477 participants. The study started on 2012-02. Estimated completion is 2015-07.
What interventions are being tested in trial NCT01601665?
The interventions under investigation include: SN6AT6 Intraocular Lens (DEVICE), SN6AT7 Intraocular Lens (DEVICE), SN6AT8 Intraocular Lens (DEVICE), SN6AT9 Intraocular Lens (DEVICE), SN60WF Intraocular Lens (DEVICE).
Who is sponsoring clinical trial NCT01601665?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.